Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Buendia Roldán (Mexico, Mexico), F. Caro (Buenos Aires, Argentina), P. Curbelo (Montevideo, Uruguay), R. Kairalla (Sao Paulo, Brazil), M. Mejia (Mexico, Mexico), L. Noriega (Panama, Panama), F. Paulin (Buenos Aires, Argentina), A. Undurraga (Santiago, Chile), M. Selman (Mexico, Mexico), O. Refipi Group (Montevideo, Uruguay). The Latin American Idiopathic Pulmonary Fibrosis Registry (REFIPI): Baseline Characteristics. 4699

Member's Comments

No comment yet.

Related content which might interest you: Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017 The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 The phenotype of the Adult Mexican Patient with Pulmonary Arterial Hypertension: Baseline characteristics of the REMEHIP Registry. The REMEHIP Investigators. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Pulmonary Embolism Registry of a South American Hospital Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Epidemiology of Idiopathic Pulmonary Fibrosis in Australia Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Baseline characteristics of 1461 participants in the Pulmonary Fibrosis Foundation Patient Registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018 Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 What can we learn from Idiopathic Pulmonary Fibrosis Registries? Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020 Phenotypes in Bronchiectasis from the EMBARC India Registry Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis:A 5-Year Cohort Study in a Azerbaijan medical University Center Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017